Scientific Research Publishing4 天
Frampton, J.E. (2018) Empagliflozin: A Review in Type 2 Diabetes. Drugs, 78, 1037-1048.
ABSTRACT: Background: Empagliflozin, an SGLT2 inhibitor, and Metformin, a biguanide, are commonly prescribed together for the management of type 2 diabetes. This study evaluates the bioequivalence of ...
Scientific Research Publishing4 天
(2025) Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products ...
ABSTRACT: Background: Empagliflozin, an SGLT2 inhibitor, and Metformin, a biguanide, are commonly prescribed together for the management of type 2 diabetes. This study evaluates the bioequivalence of ...